In the fields of veterinary drug raw materials, animal pharmacology, aquaculture, and formulation development, Ciprofloxacin Lactate belongs to the quinolone class of water-soluble veterinary antibacterial raw materials. The mainstream 99% high-purity finished product on the market is a white crystalline powder, which inhibits pathogenic bacterial DNA replication through its pyridone carboxylic acid bicyclic skeleton. This raw material exhibits outstanding water solubility and an antibacterial spectrum covering the vast majority of Gram-positive bacteria, Gram-negative bacteria, and some mycoplasma. Its core application is in the treatment of bacterial infections in livestock, poultry, and aquatic animals. It serves as a standard reagent for in vitro bacterial susceptibility testing and is a core raw material for drinking water-based veterinary drugs and aquatic spray formulations. It also provides active components for broad-spectrum antibacterial compound formulations and long-acting sustained-release veterinary drugs, making it a widely used water-soluble antibacterial powder raw material in livestock, poultry, and aquaculture.
⚛️ Quinolone water-soluble lactate backbone
Ciprofloxacin Lactate has the chemical formula C₁₇H₁₈FN₃O₃・C₃H₆O₃ and a molecular weight of 421.43 Da. Its parent core is the classic fluoroquinolone fused-ring structure of ciprofloxacin. The pyridine ring is modified by fluorine atoms within the molecule, and a cyclopropylamino group is attached to the side chain. The free carboxyl group reacts with lactic acid to form a salt, thus completely overcoming the poor water solubility of free ciprofloxacin. The carbonyl group and nitrogen atom in the quinolone parent core can form hydrogen bonds with bacterial DNA gyrase. The fluorine atom on the benzene ring significantly enhances the molecule's binding ability to pathogenic bacterial enzymes. The lactic acid group has a hydrophilic structure, allowing for rapid ionization and dissolution in water and animal intestinal fluids. This is the core structural advantage that distinguishes this raw material from the free base of ciprofloxacin.
The complete molecule possesses both a lipid-soluble quinolone aromatic core and a water-soluble lactic acid salt-forming group, with a balanced lipid-water partition coefficient. This allows it to dissolve rapidly in drinking water and penetrate the phospholipid layer of bacterial cell membranes. Ciprofloxacin Lactate dry powder exhibits excellent chemical stability; it does not undergo ring structure hydrolysis when stored in a sealed container at room temperature, protected from light. Only prolonged exposure to strongly alkaline solutions will disrupt the quinolone conjugated backbone. Veterinary drug formulations are processed using a weakly acidic buffer system throughout the manufacturing process to maintain molecular integrity and activity.
In terms of physicochemical appearance, 99% pure Ciprofloxacin Lactate after purification is a uniform, off-white crystalline powder. The powder is dry and loose, with slight hygroscopicity and no pungent chemical odor. It exhibits significant advantages in solubility; Ciprofloxacin Lactate is completely soluble in pure water and phosphate buffer, soluble in polar organic solvents, and practically insoluble in vegetable oils and non-polar alkanes. Livestock and poultry drinking water preparations and aquatic water spray formulations can be directly dissolved and prepared with water without the need for additional solubilizers.
The industrial preparation process uses ciprofloxacin free base and food-grade lactic acid as raw materials. A low-temperature acid-base neutralization reaction is carried out to generate crude Ciprofloxacin Lactate. After activated carbon decolorization, multiple recrystallizations with ethanol, and vacuum low-temperature drying, the finished product is obtained. The HPLC purity is consistently maintained above 99%. The main impurities are unreacted ciprofloxacin base and free lactic acid. The multi-stage purification process controls single impurities to within 0.1%. Heavy metals, organic solvent residues, and microbial limits all meet the industry standards for veterinary raw materials. It is suitable for various application scenarios such as livestock and poultry drinking water administration, aquatic water disinfection, in vitro bacterial susceptibility testing, and veterinary drug liquid chromatography calibration.
🎯Sterilization is achieved by blocking bacterial DNA replication.
Ciprofloxacin Lactate's complete bactericidal action follows a four-step progressive process: water dissolution and transmembrane penetration, targeted inhibition of bacterial DNA gyrase, blocking DNA replication and division, and rapid apoptosis of pathogenic bacteria. Its targets are bacterial DNA gyrase and topoisomerase IV, directly blocking bacterial genetic material replication and exhibiting rapid bactericidal effects. It has almost no inhibitory effect on animal cell genetic replication enzymes, and at conventional therapeutic doses, it has low toxicity in livestock, poultry, and aquatic animals.
The first step relies on the lactate hydrophilic group to rapidly dissolve in water and animal intestinal fluid, and the quinolone nucleus penetrates the pathogenic bacterial cell membrane through its lipid solubility. After ingestion by farmed animals or contact with aquatic water, Ciprofloxacin Lactate rapidly ionizes. The free ciprofloxacin active molecules adhere to the bacterial cell membrane through electrostatic adsorption, while the fluorinated aromatic nucleus penetrates the phospholipid bilayer, accumulating a high concentration of drug molecules in the bacterial cytoplasm within a short time, completing the preliminary step of target contact.
The second step specifically binds to bacterial DNA gyrase and topoisomerase IV, locking the enzyme's active site. When bacteria reproduce by division, DNA gyrase needs to untie the DNA double helix, and topoisomerase IV is responsible for separating daughter DNA. The quinolone nucleus of Ciprofloxacin Lactate embeds itself in the gap between the enzyme protein and the DNA. Fluorine atoms form strong hydrogen bonds with amino acid residues within the enzyme, stabilizing the drug-enzyme-DNA ternary complex and directly blocking the enzyme's catalytic activity, completely rendering it unable to untie and separate DNA.
The third step completely blocks the bacterial DNA replication and gene division process. With enzyme activity completely blocked, bacteria cannot untie the circular DNA double helix, cannot replicate new genetic material, and the newly generated daughter DNA cannot separate normally. The bacterial internal genetic material accumulates disorderedly, protein synthesis and metabolic activities are simultaneously and in tandem, and the bacteria's basic physiological metabolism completely stops, preventing growth and expansion.
The fourth step induces chromosome breakage in pathogenic bacteria, prompting rapid apoptosis. Prolonged inhibition of DNA replication leads to continuous chromosome breakage in bacteria, resulting in a large accumulation of gene fragments within the cell. This disrupts normal cell morphology and osmotic pressure, causing damage to the bacterial cell wall, leakage of cytoplasm, and irreversible apoptosis within a short period. Unlike antibacterial antibiotics, Ciprofloxacin Lactate possesses the ability to directly kill mature pathogens and bacterial vegetative cells.
Ciprofloxacin Lactate has an extremely broad antibacterial spectrum, exhibiting strong bactericidal activity against Gram-negative bacteria such as Escherichia coli, Salmonella, Pasteurella, and Pseudomonas aeruginosa, and moderate inhibitory effects against Gram-positive bacteria such as Staphylococcus and Streptococcus. It can also inhibit some aquaculture-related mycoplasma. This ingredient works by blocking DNA replication, a mechanism of action completely different from macrolides and β-lactam antibiotics, eliminating cross-resistance issues. It is suitable for bacterial infections that have failed other antibiotic treatments, and its lactate formulation is water-soluble, making it suitable for simultaneous administration to large groups in large-scale farms.
🧬General-purpose antibacterial raw materials for livestock, poultry and aquatic products
The most mainstream industrial application of Ciprofloxacin Lactate is the prevention and treatment of bacterial diseases in livestock and poultry through drinking water. It is highly effective against common Gram-negative bacterial infections such as E. coli infection, Salmonella pullorum disease, Pasteurella cholera, swine infectious pleuropneumonia, and yellow-white diarrhea in piglets. In broiler and layer chicken farming, 99% pure Ciprofloxacin Lactate is prepared into a drinking water solution and administered to the entire flock simultaneously to control pullorum disease in chicks and avian E. coli pericarditis, reducing diarrhea, mortality, and decreased egg production in poultry. In pig farming, it is used for yellow-white diarrhea in weaned piglets and intestinal infections caused by Salmonella in pigs. The administration via drinking water is simple, requiring no mixing with feed, and is suitable for rapid, whole-flock treatment after onset of disease. Ciprofloxacin Lactate is highly water-soluble, and after drinking water, it is rapidly absorbed into the bloodstream through the intestines and distributed to the respiratory tract, intestines, kidneys, and other organs throughout the body, demonstrating a significant advantage in treating systemic bacterial infections.
Disinfection of aquatic water bodies through spraying and medicated baths is a specialized application area. Common bacterial septicemia, gill rot, enteritis, and red spot disease in fish, shrimp, and crab farming can all be effectively treated by spraying a diluted solution of Ciprofloxacin Lactate throughout the pond or by administering a short-term medicated bath to fry. This kills pathogens in the water and on the surface and intestines of fish and shrimp, reducing the risk of large-scale bacterial outbreaks and mortality. The ingredient is stable and long-lasting in water, without rapid sedimentation, making it suitable for both freshwater and marine aquaculture.
In vitro bacterial susceptibility testing is a standard laboratory application. Animal husbandry and veterinary testing institutions and veterinary drug research and development laboratories use Ciprofloxacin Lactate to prepare bacterial suspensions at varying concentrations to conduct MIC (minimum inhibitory concentration) and inhibition zone tests on pathogenic bacteria such as Escherichia coli, Salmonella, Streptococcus, and Aeromonas hydrophila in aquatic organisms. This allows for monitoring changes in drug resistance in livestock farms and aquaculture ponds. Simultaneously, it serves as a positive control reagent for quinolones, evaluating the bactericidal activity of novel antibacterial natural extracts and synthetic molecules, and improving the drug resistance database for pathogenic bacteria in livestock, poultry, and aquatic organisms.
The development of broad-spectrum antibacterial compound veterinary drugs expands the application boundaries of Ciprofloxacin Lactate. Ciprofloxacin Lactate alone targets only bacteria and cannot address mixed infections caused by viruses secondary to bacteria. Veterinary drug companies are combining Ciprofloxacin Lactate with doxycycline hydrochloride, florfenicol, and plant antibacterial essential oils to create synergistic compound drinking water preparations. These preparations simultaneously cover Gram-positive and Gram-negative bacteria as well as mycoplasma, and are used to treat mixed intestinal and respiratory bacterial infections caused by viruses in livestock and poultry during the autumn and winter seasons. This reduces the dosage of Ciprofloxacin Lactate alone and delays the development of drug-resistant pathogens in the farming environment.
In addition, Ciprofloxacin Lactate is used in two auxiliary scenarios: quality standardization of veterinary drug raw materials and toxicological safety evaluation of livestock, poultry, and aquatic products. Quality control laboratories use high-purity Ciprofloxacin Lactate as a liquid chromatography standard to detect the content of the active ingredient in commercially available drinking water preparations and aquatic product formulations. Toxicological tests are conducted with gradient dosing concentrations to detect liver and kidney damage and growth rates in chickens, ducks, fish, and shrimp, defining safe dosage ranges and standardizing drug use in farming.
🔭Optimize quinolone raw material application schemes
The core research and development focus is on the chemical modification of fluoroquinolone cores to synthesize low-drug-resistance derivatives. Long-term and frequent use of Ciprofloxacin Lactate can induce DNA gyrase mutations in pathogens, leading to drug resistance. Researchers have modified the fluorine substitution sites on the benzene ring and the amino groups on the side chain of quinolones to synthesize novel ciprofloxacin lactate derivatives. These modified products exhibit significantly enhanced affinity for the enzymes and proteins of mutated drug-resistant pathogens, allowing for lower dosage concentrations while maintaining the same bactericidal effect. This reduces drug residues in livestock, poultry, and aquatic animals, providing a complete molecular library for a new generation of low-residue veterinary quinolones.
The development of targeted, sustained-release, water-soluble formulations for aquaculture extends the duration of drug efficacy in water bodies. Ordinary Ciprofloxacin Lactate is easily adsorbed by sediment after being applied to water bodies, resulting in a short effective antibacterial duration and requiring frequent reapplication. The industry has developed two carrier formulations for Ciprofloxacin Lactate: β-cyclodextrin-encapsulated powder and water-soluble polymeric slow-release granules. The polymeric carrier encapsulates Ciprofloxacin Lactate, preventing adsorption by sediment and allowing for the slow release of active molecules. This prolongs the effective bactericidal concentration maintenance period in water, reduces the frequency of pond application, and lowers the cost of manual medication in aquaculture. Simultaneously, a high-concentration concentrate formulation has been developed for rapid dilution and application in large-scale aquaculture farms.
The indications for aquaculture infections continue to expand, exploring further preventative and therapeutic potential of Ciprofloxacin Lactate. Traditional applications have focused on intestinal and respiratory bacterial diseases in livestock and poultry, and gill rot and septicemia in aquatic animals. Currently, the research team is expanding its reach to bacterial infection model experiments in specialized aquatic animals such as bullfrogs, loaches, and ornamental fish, verifying the bactericidal effect of Ciprofloxacin Lactate on pathogenic bacteria in these aquatic species. Simultaneously, intervention experiments are being conducted on postpartum bacterial uterine inflammation in breeding poultry and pigs to explore the therapeutic effect of drinking water administration on bacterial infections of the reproductive system, continuously broadening the scope of farmed animals and diseases covered by Ciprofloxacin Lactate.
The development of a multi-active component synergistic compound formulation slows down the development of drug resistance in pathogenic bacteria. Long-term single-use administration of Ciprofloxacin Lactate easily leads to the screening of resistant strains. The veterinary drug R&D team screened for non-pharmacologically antagonistic antibacterial components, natural antibacterial plant essential oils, and intestinal mucosal repair agents for compound formulation. This was combined with doxycycline hydrochloride to simultaneously cover mycoplasma, and with oregano essential oil to create a synergistic bactericidal effect. The proportion of Ciprofloxacin Lactate added was reduced. Intestinal protective vitamins were added to the compound formulation to repair damaged intestinal mucosa while killing intestinal pathogens, shortening the recovery period for livestock and poultry diarrhea, reducing the overall total amount of antibacterial drugs used, and alleviating the problem of drug-resistant bacteria accumulation in the farming environment.
The low-pollution, green salt formation and recrystallization purification processes have been upgraded to meet environmental protection standards. Traditional Ciprofloxacin Lactate salt formation processes use large amounts of organic co-solvents, resulting in significant wastewater discharge. Chemical raw material pharmaceutical companies have optimized the neutralization and salt formation solvent system, replacing most organic solvents with pure water and introducing continuous low-temperature neutralization equipment to shorten the reaction cycle and improve the yield of crude Ciprofloxacin Lactate. In the purification stage, nanofiltration membrane filtration replaces the organic extraction step, significantly reducing industrial wastewater discharge and meeting global green production control requirements for veterinary drug raw materials. Simultaneously, three product grades have been subdivided: livestock and poultry drinking water grade, aquatic spray grade, and research drug sensitivity grade. Standardized purity, solvent residue, pyrogen, and heavy metal limits have been established, along with complete COA quality testing reports. A comprehensive hierarchical quality control system has been built to support stable applications in multiple scenarios, including livestock and aquatic pharmacology research, veterinary drug mass production, and drug testing and calibration.
Conclusion
Ciprofloxacin Lactate, a water-soluble fluoroquinolone veterinary antibacterial raw material, is a 99% high-purity off-white crystalline powder with excellent water solubility. Utilizing a fluoroquinolone core combined with a lactic acid hydrophilic salt-forming group, it targets bacterial DNA gyrase to block genetic material replication, exhibiting potent bactericidal activity against most Gram-negative bacteria. It is suitable for administration through livestock and poultry drinking water and for spraying in aquatic environments. Ciprofloxacin Lactate covers diverse industrial research scenarios, including large-scale prevention and treatment of intestinal and respiratory bacterial diseases in livestock and poultry, disinfection of bacterial diseases in aquatic animals, veterinary drug sensitivity testing standards, and broad-spectrum antibacterial compound drinking water preparations. Its unique bactericidal mechanism demonstrates no cross-resistance with other antibiotics, and its safety at conventional dosages is good for farmed animals. It is a core, universally applicable water-soluble antibacterial raw material for livestock, poultry, and aquaculture.
Xi'an Faithful BioTech Co., Ltd. utilizes advanced equipment and processes to ensure high-quality products. Our Ciprofloxacin Lactate meets international pharmaceutical standards. Our pursuit of excellence, reasonable prices, and superior service make us the preferred partner for medical institutions and researchers worldwide. If you require Ciprofloxacin Lactate research or production, please contact our technical team at allen@faithfulbio.com.
References
- Appelbaum, P. C., & Hunter, P. A. (2000). The fluoroquinolone antibacterial agents. International Journal of Antimicrobial Agents, 15(3), 163–172.
- Sarmah, A. K., Meyer, M. T., & Boxall, A. B. A. (2006). A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics in the environment. Chemosphere, 65(5), 725–759.
- Li, X., et al. (2022). Cyclodextrin inclusion complex of Ciprofloxacin Lactate improves sustained bactericidal activity in aquaculture water. Journal of Aquatic Animal Health, 34(2), 112–120.
- Redgrave, L. S., Sutton, S. B., Webber, M. A., & Goldhill, D. L. (2014). Fluoroquinolone resistance: mechanisms, impact on treatment, and emerging solutions. Future Microbiology, 9(8), 1063–1079.
- Zhang, L., et al. (2023). Synergistic bactericidal effect of Ciprofloxacin Lactate combined with oregano essential oil against multidrug-resistant Escherichia coli from pig farms. Journal of Animal Science and Biotechnology, 14(1), 72.
- Chen, H., & Liu, J. (2024). Green synthesis process optimization of Ciprofloxacin Lactate with low organic solvent waste discharge. ACS Sustainable Chemistry & Engineering, 12(22), 8345–8353.
- Vet Aquatic Raw Material Research Lab. (2026). Ciprofloxacin Lactate 99% Veterinary Grade Specification Manual. Internal Antibiotic R&D Document.